Secor Capital Advisors’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Secor Capital Advisors’s Portfolio BSTC Stock Details BSTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-13,196	Closed	-$592K	–	622
2018 Q2	$592K	Sell	13,196 -3,780	-22%	-$163K	0.05%	362
2018 Q1	$753K	Buy	16,976 +121	+0.7%	+$5.08K	0.06%	325
2017 Q4	$730K	Sell	16,855 -111	-0.7%	-$4.99K	0.03%	320
2017 Q3	$789K	Hold	16,966	–	–	0.08%	297
2017 Q2	$840K	Sell	16,966 -197	-1%	-$10.3K	0.08%	295
2017 Q1	$941K	Sell	17,163 -577	-3%	-$30.5K	0.1%	249
2016 Q4	$988K	Sell	17,740 -4,749	-21%	-$228K	0.12%	234
2016 Q3	$1.03M	Buy	22,489 +5,832	+35%	+$234K	0.11%	248
2016 Q2	$665K	Buy	16,657 +9,046	+119%	+$331K	0.08%	320
2016 Q1	$265K	Buy	+7,611	New	+$279K	0.04%	472

Other funds holding BSTC

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

ECP

Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return

TAM

THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Secor Capital Advisors's BSTC Position: Q3 2018 in Review

Secor Capital Advisors sold out of BioSpecifics Technologies Corp. (BSTC) in Q3 2018, closing a stake of 13,196 shares — an estimated $592K sold.

Secor Capital Advisors first reported a position in BSTC in Q1 2016 and held it in 10 quarters. The position peaked at $1.03M in Q3 2016. 93 funds tracked by Wall St. Rank hold BSTC as of Q3 2018.

Secor Capital Advisors reported no remaining BioSpecifics Technologies Corp. position as of Q3 2018 after selling out during the quarter.
Secor Capital Advisors sold 13,196 BioSpecifics Technologies Corp. shares in Q3 2018, an estimated $592K.
Secor Capital Advisors first reported a position in BioSpecifics Technologies Corp. in Q1 2016 and held it in 10 quarters.
Secor Capital Advisors's BioSpecifics Technologies Corp. position peaked at $1.03M in Q3 2016.
93 funds tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q3 2018.

Based on Secor Capital Advisors's 13F filing for Q3 2018, filed 14 Nov 2018.